Company Encyclopedia
View More
name
Intercure
INCR.US
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with Cannasoul R&D Ltd.
4.654 T
INCR.USMarket value -Rank by Market Cap -/-

Financial Score

22/12/2025 Update
D
PharmaceuticalsIndustry
Industry Ranking150/186
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-15.91%E
    • Profit Margin-29.18%E
    • Gross Margin30.94%C
  • Growth ScoreD
    • Revenue YoY-8.26%D
    • Net Profit YoY-11.21%D
    • Total Assets YoY13.02%B
    • Net Assets YoY4.18%C
  • Cash ScoreD
    • Cash Flow Margin-342.76%D
    • OCF YoY-8.26%D
  • Operating ScoreD
    • Turnover0.33D
  • Debt ScoreC
    • Gearing Ratio42.50%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    InterCure Ltd On Dec 15, Became Aware That Bazelet Group Of Companies Has Initiated Restructuring Proceedings Before The Israeli District Court

    InterCure Ltd :INTERCURE LTD: ON DEC 15, BECAME AWARE THAT BAZELET GROUP OF COMPANIES HAS INITIATED RESTRUCTURING PROCEEDINGS BEFORE THE ISRAELI DISTRICT COURTINTERCURE: PLANS TO PURSUE APPROPRIATE LEGAL ACTIONS IN CONNECTION WITH BAZELET'S RESTRUCTURING PROCEEDINGS

    Reuters·
    US
    INCR
    -9.56%
    Reuters·
    US
    INCR
    -9.56%

    InterCure Ltd. Announces Date for Upcoming Annual General Meeting of Shareholders

    InterCure Ltd. will hold its Annual General Meeting of Shareholders on December 30, 2025, in Tel Aviv, Israel. Shareholders will vote on the re-election of Alexander Rabinovich, Alon Granot, and David Salton to the board of directors. The meeting details were published via EDGAR by InterCure Ltd.

    Reuters·
    US
    INCR
    -9.56%
    Reuters·
    US
    INCR
    -9.56%

    InterCure Acquires 28% Stake in Cannasoul

    InterCure Ltd. has acquired a 28% stake in Cannasoul R&D Ltd. through a Share Purchase Agreement, with an option to increase its ownership to 51% within two years. This investment aims to enhance cannabis science and pharmaceutical innovation by leveraging Cannasoul’s research and InterCure’s platform. The deal is subject to regulatory approvals and customary closing conditions.

    Reuters·
    US
    INCR
    -9.56%
    Reuters·
    US
    INCR
    -9.56%

    InterCure reports NIS 130 million revenue and positive operating cash flow for first half 2025

    InterCure Ltd. reported NIS 130 million in revenue for H1 2025, with an Adjusted EBITDA of NIS 12.6 million, marking the eleventh consecutive half of positive EBITDA. The company generated positive cash flow from operations of NIS 12 million, a significant improvement from a negative cash flow of NIS 43 million in the previous year. Cash on hand increased to NIS 54 million, and shareholders’ equity reached NIS 432 million. InterCure also received NIS 81 million in compensation for war-related damages and entered a share purchase agreement to acquire Botanico Ltd.

    Reuters·
    US
    INCR
    -9.56%
    Reuters·
    US
    INCR
    -9.56%

    Middle Eastern Penny Stocks With Market Caps Over US$1M

    The Middle Eastern stock markets are experiencing mixed movements, with Saudi losses due to profit-taking and Qatar's index rising. Penny stocks, often overlooked, present affordable investment opportunities with potential growth. Notable stocks include Maharah for Human Resources, Thob Al Aseel, and Alarum Technologies, among others. The National Bank of Umm Al-Qaiwain shows solid market capitalization but faces challenges with bad loans. InterCure operates in the cannabis sector but is unprofitable, while SavorEat, focused on meat substitutes, is pre-revenue and faces financial difficulties. Investors are encouraged to explore these under-the-radar options.

    Simplywall·
    US
    INCR
    -9.56%
    US
    ALAR
    -3.45%
    Simplywall·
    US
    INCR
    -9.56%
    US
    ALAR
    -3.45%
    © 2025 Longbridge｜Disclaimer